Cannabis Industry Shifts Lobbying Dollars to GOP Ahead of 2026 Midterms

GOP Candidates Receive Surge in Cannabis PAC Donations

Cannabis political action committees contributed $8.2 million to Republican congressional candidates in the first half of 2026, up from $2.4 million in the same period last year. The National Cannabis Industry Association PAC, the U.S. Cannabis Council PAC, and the Hemp Roundtable PAC account for 71% of that total, according to FEC records filed through June 30, 2026.

The shift follows stalled progress on the SAFER Banking Act, which hasn't advanced past committee markup in the current Congress despite bipartisan sponsorship. Multi-state operators including Curaleaf, Trulieve, and Green Thumb Industries have each contributed the maximum allowable $5,000 per candidate to Republican incumbents on the House Financial Services Committee and Senate Banking Committee.

Republican candidates in swing districts with active hemp and cannabis cultivation economies—Ohio, Pennsylvania, North Carolina, and Arizona—received 62% of the industry's Q2 2026 contributions.

Hemp Industry Targets GOP Over THCA and Delta-8 Crackdowns

Hemp trade groups are lobbying Republican state legislators to block total-THC testing mandates that would effectively ban THCA flower and converted cannabinoids. The Hemp Roundtable spent $1.4 million on state-level lobbying in 2026. Seventy-eight percent went to Republican-controlled legislatures in Texas, Florida, Georgia, and Tennessee, according to state disclosure filings.

The hemp industry's survival depends on preserving the delta-9 THC threshold in the 2018 Farm Bill—total-THC testing would collapse the $28 billion hemp-derived cannabinoid market overnight.

Florida's HB 1475, which advanced out of committee in May 2026, would require total-THC testing and reclassify THCA flower as marijuana. The Hemp Roundtable and the U.S. Hemp Authority contributed $340,000 to Republican sponsors and leadership PACs opposing the bill's floor vote.

North Carolina's SB 711, signed into law in June 2026, preserved delta-9 testing after hemp processors contributed $290,000 to GOP legislators. That law explicitly excludes THCA from the state's marijuana definition.

MSOs Seek 280E Relief Through Republican Tax Reform Proposals

Cannabis operators paid an estimated $1.8 billion in additional federal taxes under Section 280E in 2025. Multi-state operators are now backing Republican tax reform proposals that would allow standard business deductions. The CLAIM Act (HR 2378), introduced by Rep. Dave Joyce (R-OH) in March 2026, would permit cannabis businesses to deduct ordinary expenses while marijuana remains Schedule I or II.

The bill has 24 Republican co-sponsors and zero Democratic co-sponsors as of July 2026. Trulieve's PAC contributed $125,000 to Joyce's re-election campaign and an additional $85,000 to co-sponsors in the House Ways and Means Committee.

Industry analysts estimate that 280E relief would increase MSO net margins by 12-18 percentage points. Curaleaf's Q1 2026 earnings call cited 280E as the company's largest non-operating expense, totaling $47 million in the quarter.

Rescheduling Delay Accelerates Bipartisan Fatigue

The DEA's rescheduling process has stalled at the administrative law judge review stage since February 2026. No hearing date is set as of July 25. The delay has shifted industry strategy from federal decriminalization advocacy to state-by-state operational wins and targeted tax reform.

Democratic leadership in the Senate hasn't scheduled floor time for cannabis banking or decriminalization bills in 2026. The SAFER Banking Act remains in committee despite passing the House in September 2025. The industry's pivot toward Republican candidates reflects a pragmatic read: incremental wins on banking, taxes, and hemp regulation are more achievable than comprehensive reform.

For full background on this story, see the CannIntel topic hub on cannabis industry GOP relations.

What This Means for Operators and Investors

The industry's rightward tilt signals a strategic recalibration—operators are prioritizing business-friendly tax and banking policy over social-equity and decriminalization messaging. That shift has drawn criticism from advocacy groups including the Drug Policy Alliance and the Marijuana Policy Project, which argue that the industry is abandoning criminal-justice reform in favor of corporate profit protection.

• MSOs with exposure to 280E liability are the primary beneficiaries of Republican tax proposals.
• Hemp processors in states with total-THC testing proposals face existential regulatory risk and are concentrating lobbying dollars accordingly.
• Investors should monitor state-level hemp bills in Florida, Texas, and Georgia—passage of total-THC mandates would trigger margin compression for delta-8 and THCA distributors.

The math is hard to argue with. If rescheduling remains stalled and Democrats can't move banking reform, the industry's survival depends on Republican votes for tax relief and hemp preservation. That's the trade the industry is making.